Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center-Reference-Cited by-同舟云学术

Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center

Published:2014-05 Issue:2 Volume:133 Page:142-146
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Erickson Britt K.,Martin Jovana Y.,Shah Monjri M.,Straughn J. Michael,Leath Charles A.^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference12 articles.

1. Ovarian cancer, version 2.2013;Morgan;J Natl Compr Canc Netw,2013

2. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status;Bristow;J Natl Cancer Inst,2013

3. Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy?;Chase;Obstet Gynecol,2012

4. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center;Bristow;Gynecol Oncol,2011

5. Surgical outcomes and national comprehensive cancer network compliance in advanced ovarian cancer surgery in a low volume military treatment facility;Phippen;Gynecol Oncol,2013

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term survival analysis of a risk-adjusted model for ovarian cancer care;Gynecologic Oncology;2024-05

2. Health disparities related to aging;Healthcare Disparities in Otolaryngology;2024

3. Health Disparities in Ovarian Cancer;Obstetrics & Gynecology;2023-06-07

4. The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression via activation of the Wnt/β-catenin signaling pathway;Frontiers in Immunology;2023-05-25

5. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers;Future Oncology;2023-04